News
But Novo Nordisk, the Danish pharma large behind the ‘miracle’ drug, has already admitted that just a ‘proportion’ of already limited stock might be shared with the health service, with the rest allotted to non-public corporations. Experts hit out at the move, arguing that ‘would not make sense’ and can leave those most in want with out access to Wegovy. About 180,000 Brits with type 2 diabetes are set to be given tirzepatide to assist control their condition, trials have also proven individuals taking the jab can lose up to 20 per cent of their physique weight. Taken once every…